Abbott gets EU approval of Crohn's disease drug
Mass High Tech
A drug approved to treat moderately-active Crohn's disease, a chronic inflammatory bowel disease of the gastrointestinal tract, in the European Union has been approved to treat severely active patients with the disease. Abbott Laboratories (NYSE: ABT), …
Abbott's Humira cleared for Crohn's disease in EUThe Pharma Letter
Abbott Labs: FDA Panel Backs Humira for Colitis, Gets Additional Treatment …Trefis

all 3 news articles

Leave a Reply